Dilemma of stage II colon cancer and decision making for adjuvant chemotherapy

J Am Coll Surg. 2014 Nov;219(5):1056-69. doi: 10.1016/j.jamcollsurg.2014.09.010. Epub 2014 Sep 19.

Authors

Sandy H Fang¹, Jonathan E Efron¹, Mariana E Berho², Steven D Wexner³

Affiliations

¹ Colon and Rectal Surgery, Department of Surgery, Ravitch Division, Johns Hopkins Medical Center, Baltimore, MD.
² Department of Pathology, Cleveland Clinic Florida, Weston, FL. Electronic address: berhom@ccf.org.
³ Department of Colorectal Surgery, Cleveland Clinic Florida, Weston, FL.

PMID: 25440029
DOI: 10.1016/j.jamcollsurg.2014.09.010

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Agents / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Chemotherapy, Adjuvant
Colectomy*
Colonic Neoplasms / drug therapy*
Colonic Neoplasms / pathology
Colonic Neoplasms / surgery
Decision Support Techniques
Humans
Neoplasm Staging
Practice Guidelines as Topic
Prognosis

Substances

Antineoplastic Agents